Actelion

Acquired

Johnson & Johnson Innovative Medicine

Allschwil, Switzerland · Founded 1997 · $46.0M raised

Headquarters
Allschwil
Employees
1001–5000
Founded
1997
Business Model
B2B
Total Funding
$46.0M
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Actelion Pharmaceuticals Ltd. is a Swiss biopharmaceutical company founded in 1997 and headquartered in Allschwil, near Basel, Switzerland. The company specialized in the discovery, development, and commercialization of drugs for rare and orphan diseases, with a primary focus on pulmonary arterial hypertension (PAH). Its key products include Tracleer (bosentan), the first oral therapy approved for PAH; Opsumit (macitentan); Uptravi (selexipag); Ventavis (iloprost); and Veletri (epoprostenol). In January 2017, Johnson & Johnson acquired Actelion for billion, and Actelion's R&D unit was spun off as Idorsia, listed on the SIX Swiss Exchange in June 2017.

Summary

Actelion is a Biotech company based in Allschwil, Switzerland, founded in 1997. It has raised $46.0M in total across 2 rounds. Investors include TVM Capital and Atlas Venture.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B
$34.0M

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Actelion on Indexed.vc
<a href="https://indexed.vc/companies/actelion"><img src="https://indexed.vc/api/badge/company/actelion" alt="Actelion on Indexed.vc" width="260" height="76" /></a>